Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Michael Boxer, MD

Blood (2019) 134 (Supplement_1): 962.

https://doi.org/10.1182/blood-2019-122154

Published: 2019

Journal Articles

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

Chris LaVallee, M.S, Patrick Cronin, M.A, Isha Bansal, M.S, Jackie Kwong, PhD PharmD, Ralph Boccia, MD

Blood (2019) 134 (Supplement_1): 3445.

https://doi.org/10.1182/blood-2019-125793

Published: 2019

Journal Articles

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

Janice Kim, PharmD, MSc, Bindu Kanapuru, MD, Jessica K Roydhouse, PhD MPH, Ann T. Farrell, MD, Najat Bouchkouj, MD, Hussein Ezzeldin, PhD, Paul Kluetz, MD

Blood (2019) 134 (Supplement_1): 3450.

https://doi.org/10.1182/blood-2019-125798

Published: 2019

Journal Articles

Safety and Efficacy of 1020 Mg Total Dose Infusion of Ferumoxytol in a Veterans Health System

Paige May, PharmD, Preetika Pai, PharmD, Katherine Boles, PharmD, BCPS, Ashley McGee, PharmD, MBA, BCOP, Jess David Delaune, MD, Tanaka Dang, BS, Jessica M. Schmit, MD

Blood (2019) 134 (Supplement_1): 3538.

https://doi.org/10.1182/blood-2019-130709

Published: 2019

Journal Articles

Efficacy and Safety of Low Molecular Weight Iron Dextran (LMWID) Vs. Ferumoxytol in Treating Iron Deficiency Anemia

Arpine Khudanyan, BS, Sven Reid Olson, MD, Thomas G. Deloughery, MD, Joseph J Shatzel, MD

Blood (2019) 134 (Supplement_1): 2449.

https://doi.org/10.1182/blood-2019-129653

Published: 2019

Journal Articles

Severe Hypophosphatemia in Patients with Cancer Following IV Iron Treatment: Results from a Large Comparative Trial

Ralph V. Boccia, MD, Naomi V Dahl, PharmD, William E Strauss, MD

Blood (2019) 134 (Supplement_1): 2236.

https://doi.org/10.1182/blood-2019-126149

Published: 2019

Journal Articles

Sustained Improvements in Fatigue and Quality of Life in Iron Deficiency Anemia Patients Following a Single Course of Ferumoxytol: Results of a 6-Month Extension Study

Saroj Vadhan-Raj, MD, Naomi V Dahl, PharmD, John Jiang, PhD, William E Strauss, MD

Blood (2018) 132 (Supplement 1): 1050.

https://doi.org/10.1182/blood-2018-99-115511

Published: 2018

Journal Articles

The Safety and Efficacy of Ferumoxytol in the Treatment of Iron Deficiency: A Systematic Review and Meta-Analysis

Jameel Abdulrehman, MD, Grace Tang, MSc, Michael Auerbach, MD, Michelle Sholzberg, MDM, MSc, FRCPC

Blood (2018) 132 (Supplement 1): 4894.

https://doi.org/10.1182/blood-2018-99-114146

Published: 2018

Journal Articles

Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy

Michael Auerbach, MD, William E Strauss, MD, Iain C. Macdougall, MD, Kristine Bernard, MPH, Robert F Kaper, MD, Glenn M Chertow, MD MPH, Zhu Li, PhD, Anton Trochanov, MD, Naomi V Dahl, PharmD, Julie Krop, MD

Blood (2017) 130 (Supplement 1): 3500.

https://doi.org/10.1182/blood.V130.Suppl_1.3500.3500

Published: 2017

Journal Articles

Real World Outcomes of Ferric Carboxymaltose and Ferumoxytol Iron Replacement Therapy: A Retrospective Analysis of Electronic Health Records

Chunlin Qian, PhD, Winghan Jacqueline Kwong, PhD PharmD

Blood (2017) 130 (Supplement 1): 2087.

https://doi.org/10.1182/blood.V130.Suppl_1.2087.2087

Published: 2017

Journal Articles

Red Blood Cell Transfusions Shape Macrophages Towards an Anti-Inflammatory Functional Phenotype and Impair the Immune Response to Infectious Cues

Francesca Vinchi, Milene Costa da Silva, Richard Sparla, Heike Weidner, Martina Rauner, Emanuela Tolosano, Uwe Platzbecker, MD, Martina U. Muckenthaler

Blood (2017) 130 (Supplement 1): 227.

https://doi.org/10.1182/blood.V130.Suppl_1.227.227

Published: 2017

Journal Articles

Iron Supplementation: What's New?

Iain C. Macdougall, MD

Blood (2017) 130 (Supplement 1): SCI-43.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-43.SCI-43

Published: 2017

Journal Articles

Ferumoxytol-Contrasted MRI for Macrophage Imaging of Inflammation in Human Osteomyelitis, a Feasibility Study

Alexander Neuwelt, Marisa Rivera, Jonathan Orner, Thomas Byrd, Laurel Sillerud, Gary Mlady, Justin Baca, Jens Langsjoen

Blood (2015) 126 (23): 1016.

https://doi.org/10.1182/blood.V126.23.1016.1016

Published: 2015

Journal Articles

Safety and Efficacy of Ferumoxytol for the Treatment of Iron Deficiency Anemia in a Community Based Hematology Clinic

Erin DeBolt, B.S., PharmD candidate 2016, John A Wagoner, BS candidate 2016, Mark Tharnish, PharmD, Mithat Gonen, PhD, Dron Gauchan, MD, Ryan C. Ramaekers, MD, Douglas Clark, MD, Max Norvell, PharmD, Mehmet Copur, MD

Blood (2015) 126 (23): 4553.

https://doi.org/10.1182/blood.V126.23.4553.4553

Published: 2015

Journal Articles

Experience of a Single Latin-American Institution Using a Colloidal Iron Oxide Coated with a Semisynthetic Carbohydrate (ferumoxytol) for Iron Deficiency Anemia (IDA) in Patients with Intolerance or Treatment Failure with Oral Iron

Roberto Ovilla, MD, Dannia Calles-Payan, MD, Lucia A Reynolds-Ocampo, MD, Gabriela Ruiz-Reyes, Nurse, Carolina Balderas-Delgado, MD, Andres Montesinos-Ovilla, Alvaro Cabrera Garcia, MD

Blood (2014) 124 (21): 4887.

https://doi.org/10.1182/blood.V124.21.4887.4887

Published: 2014

Journal Articles

Effect of DMSA Modified Fe3O4 and Multidrug Resistance Modulator HZ08 on the Reversal of Multidrug Resistance in K562/A02 Cell Line

Fei Shen, Master, Mingfei Zhou, Xuzhang Lu, PhD, Yanping Chen, undergraduate, Baoan Chen, PhD Professor

Blood (2014) 124 (21): 5235.

https://doi.org/10.1182/blood.V124.21.5235.5235

Published: 2014

Journal Articles

Efficacy and Safety of IV Ferumoxytol (FER) for Iron Deficiency Anemia (IDA) in Patients with Cancer

Saroj Vadhan-Raj, MD, Naomi V. Dahl, Pharm D, Kristine Bernard, MPH, Zhu Li, PhD, William Strauss, MD, F.A.C.C.

Blood (2014) 124 (21): 1352.

https://doi.org/10.1182/blood.V124.21.1352.1352

Published: 2014

Journal Articles

Generating Chimeric Antigen Receptors Utilizing Novel Anti-CD3 Nanobeads

Liora M. Schultz, MD, Debra K Czerwinski, Aihua Fu, PhD, Shoshana Levy, PhD, Ronald Levy, MD

Blood (2014) 124 (21): 5949.

https://doi.org/10.1182/blood.V124.21.5949.5949

Published: 2014

Journal Articles

Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve Immunogenicity of Myeloma Tumor Antigen to Enhance Th1 Polarization of Dendritic Cells

My-Dung Hoang, Hwa-Jeong Lee, Hyun-Ju Lee, Sung-Hoon Jung, Nu-Ri Choi, Manh-Cuong Vo, Thanh-Nhan Nguyen-Pham, In-Kyu Park, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD

Blood (2014) 124 (21): 5763.

https://doi.org/10.1182/blood.V124.21.5763.5763

Published: 2014

Journal Articles

Antitumor Efficacy Of DMSA Modified Fe 3 O 4 magnetic Nanoparticles Combined With Arsenic Trioxide and Adriamycin In Jurket Cells

Cai Xiaohui, Chunling Wang, Baoan Chen, PHD, Professor, Weijun Hua, Fei Shen, Liang Yu, PHD, Zhengmei He, Yue Chen, Guohua Xia, Jian Cheng, PhD,, Wen Bao, Yu Zhang, PHD, Xuemei Wang, PHD, Senthilkumar Ravichandran

Blood (2013) 122 (21): 4917.

https://doi.org/10.1182/blood.V122.21.4917.4917

Published: 2013

NARROW

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

Safety and Efficacy of 1020 Mg Total Dose Infusion of Ferumoxytol in a Veterans Health System

Efficacy and Safety of Low Molecular Weight Iron Dextran (LMWID) Vs. Ferumoxytol in Treating Iron Deficiency Anemia

Severe Hypophosphatemia in Patients with Cancer Following IV Iron Treatment: Results from a Large Comparative Trial

Sustained Improvements in Fatigue and Quality of Life in Iron Deficiency Anemia Patients Following a Single Course of Ferumoxytol: Results of a 6-Month Extension Study

The Safety and Efficacy of Ferumoxytol in the Treatment of Iron Deficiency: A Systematic Review and Meta-Analysis

Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy

Real World Outcomes of Ferric Carboxymaltose and Ferumoxytol Iron Replacement Therapy: A Retrospective Analysis of Electronic Health Records

Red Blood Cell Transfusions Shape Macrophages Towards an Anti-Inflammatory Functional Phenotype and Impair the Immune Response to Infectious Cues

Iron Supplementation: What's New?

Ferumoxytol-Contrasted MRI for Macrophage Imaging of Inflammation in Human Osteomyelitis, a Feasibility Study

Safety and Efficacy of Ferumoxytol for the Treatment of Iron Deficiency Anemia in a Community Based Hematology Clinic

Experience of a Single Latin-American Institution Using a Colloidal Iron Oxide Coated with a Semisynthetic Carbohydrate (ferumoxytol) for Iron Deficiency Anemia (IDA) in Patients with Intolerance or Treatment Failure with Oral Iron

Effect of DMSA Modified Fe3O4 and Multidrug Resistance Modulator HZ08 on the Reversal of Multidrug Resistance in K562/A02 Cell Line

Efficacy and Safety of IV Ferumoxytol (FER) for Iron Deficiency Anemia (IDA) in Patients with Cancer

Generating Chimeric Antigen Receptors Utilizing Novel Anti-CD3 Nanobeads

Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve Immunogenicity of Myeloma Tumor Antigen to Enhance Th1 Polarization of Dendritic Cells

Antitumor Efficacy Of DMSA Modified Fe 3 O 4 magnetic Nanoparticles Combined With Arsenic Trioxide and Adriamycin In Jurket Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only